NEWS ARCHIVE
iCHOR news AND press releases
| Title | Date |
|---|---|
| Ichor Vascular Commences Limited Market Release of 7-F Peripheral Reperfusion System | February 27, 2025 |
| Ichor Vascular’s 14-F Peripheral Reperfusion System Cleared by FDA | July 18, 2024 |
| Ichor Vascular’s 14-F Peripheral Reperfusion System Cleared by FDA | September 10, 2023 |
| Ichor Vascular’s Arterial and Venous Solutions Granted European Patent Approval | April 24, 2023 |
| Ichor’s Venous Peripheral Reperfusion System Submitted to FDA for Clearance | March 17, 2023 |
| Featured in Vascular Disease Management (VDM): ICHOR and Naglreiter Elevator Incubator Innovating MedTech | February 28, 2020 |
| iCHOR Case Study with NAMSA | January 16, 2020 |
| iCHOR Vascular Featured in Endovascular Today | April 30, 2019 |
| iCHOR Vascular Announces FDA Clearance of the iCHOR Reperfusion System | January 14, 2019 |
About iCHOR
iCHOR was founded by Interventional Radiologist Dr. Troy Long and industry veteran Tim Blair. They identified an opportunity to develop new technologies to address these large unmet needs in treating peripheral vascular occlusions. This collaboration has lead to the development of the iSWEEP platform technology that has converted the tried and true Fogarty balloon sweep technique from an open surgery to a simple, minimally-invasive endovascular procedure.
